In HHT patients, chronic inflammation, endothelial damage, shear stress, increased FVIII, and von Willebrand factor levels due to bleeding bring about an increase in the risk of thrombosis. This evidence concerns the gene VWF and hereditary hemorrhagic telangiectasia.